# Roivant Sciences Ltd.: Form SCHEDULE 13D/A, filed Oct 5, 2026

- Company: [Roivant Sciences Ltd.](/companies/roiv.md) (CIK 1635088)
- Form: SCHEDULE 13D/A
- Filed: 2026-10-05
- Accepted by EDGAR: Oct 5, 2026, 21:02 ET
- Period: not reported
- Accession: 0001140361-26-038693
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1635088/000114036126038693/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1635088/000114036126038693/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1635088/000114036126038693/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Oct 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-038693. Last ingested by Listed: Nov 5, 2026, 21:32 ET. No prices; not investment advice.